CVS Health downgraded to Hold due to political risks, declining cash flow, and industry battles despite strong Q4 sales and a ...

PBM reform represents a tremendous opportunity. It might be one of the only significant, consequential areas of true ...

Fintel reports that on February 13, 2025, Leerink Partners upgraded their outlook for CVS Health (NYSE:CVS) from Market ...

During the last three months, 11 analysts shared their evaluations of CVS Health CVS +0.18% Get Free Report , revealing ...

Shares of CVS Health Corporation (NYSE: CVS) experienced a jolt, rising over 15% on February 12, 2025, as the market responded to the release of its fourth-quarter 2024 earnings report. CVS Health's ...

Full Year 2024 Results Key Financial Results Revenue: US$372.8b (up 4.5% from FY 2023).

CVS Health Corp issued an optimistic guidance for 2025 stemming from the expected recovery in its insurance business — ...

A Leerink analyst says CVS is starting to benefit from stabilization in its Aetna health-insurance and pharmacy-benefits ...

CVS Health (CVS) stock soared about 15% yesterday after posting upbeat fourth-quarter results, with revenues and earnings surpassing analysts’ ...

CVS Health CEO David Joyner sees a way to create a more efficient healthcare professional network under the CVS umbrella.

Truist analyst David MacDonald raised the firm’s price target on CVS Health (CVS) to $76 from $60 and keeps a Buy rating on the shares after ...

“We see the reward as positively skewed on a risk-adjusted basis,” analysts at Leerink Partners wrote, citing improving ...